| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19K | 13 May 2025 | Direct | ||
| BiomX Inc. | Director | Common Stock Options - right to Buy | 17.6K | 14 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | 13 May 2025 | 1 | $0 | 4 | Director | 14 May 2025, 16:32 |
| PHGE | BiomX Inc. | 14 Apr 2025 | 1 | $0 | 4/A | Director | 21 Apr 2025, 08:00 |
| PHGE | BiomX Inc. | 11 Jul 2024 | 1 | $0 | 4 | Director | 15 Jul 2024, 18:44 |
| LRMR | Larimar Therapeutics, Inc. | 29 May 2024 | 1 | $0 | 4 | Director | 31 May 2024, 16:57 |
| PHGE | BiomX Inc. | 15 Mar 2024 | 0 | $0 | 3 | Director | 21 Mar 2024, 16:29 |
| LRMR | Larimar Therapeutics, Inc. | 09 May 2023 | 1 | $0 | 4 | Director | 11 May 2023, 16:29 |
| SPRY | ARS Pharmaceuticals, Inc. | 08 Nov 2022 | 0 | $0 | 3 | Director | 10 Nov 2022, 16:00 |
| LRMR | Larimar Therapeutics, Inc. | 10 May 2022 | 1 | $0 | 4 | Director | 12 May 2022, 20:27 |
| LRMR | Larimar Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 17 May 2021, 17:09 |